Alternating combination of alkylating agents and vincristine, doxorubicin, and dexamethasone in multiple myeloma.
Lejeune
C
C
Sotto
J J
JJ
Fuzibet
J G
JG
Rossi
J F
JF
Lepeu
G
G
Bataille
R
R
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D015996:Survival Rate; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin